YOKNEAM, Israel and PALO ALTO, California, September 5 /PRNewswire/ --     UltraShape, a global leader in non-invasive body contouring, today
announced it has completed a $15.1 million round of funding. The financing
was led by new investor Meritech Capital Partners, with participation from
both of its previous institutional investors, Israel Seed Partners and
Polaris Venture Partners.

"Our style of investing targets late-stage companies that are best in
class," said Rob Ward, a founder and managing director at Meritech. "We have
been very impressed by UltraShape's technology, its ability to penetrate
global markets and its management team, and are very confident that
UltraShape will maintain its leadership position in the field of non-invasive
body contouring solutions."

"We are very pleased to have Meritech join the UltraShape team," said
Rodger Stewart, UltraShape President and CEO. "The infusion of capital will
enable UltraShape to accelerate global market adoption to meet the growing
demands for our body contouring solution. We are confident that Meritech's
experience and expertise will contribute significantly as UltraShape grows to
become a global leader in the aesthetics industry."

About UltraShape

UltraShape is redefining aesthetic medicine by developing, manufacturing
and marketing innovative non-invasive technologies for body contouring. The
company is dedicated to providing clinically proven safe and effective
solutions that enhance the lives of patients worldwide. The UltraShape
proprietary non-invasive body contouring technology is based on focused
ultrasound that targets and selectively disrupts fat cells without affecting
surrounding structures. Founded in 2000, UltraShape is a privately held and
venture backed company with offices in the United States, Israel, France,
United Kingdom, and Italy. The UltraShape system is not cleared by the FDA
for marketing in the United States. For more information visit
http://www.ultrashape.com.

About Meritech Capital Partners

Meritech Capital Partners is a leading provider of late-stage venture
capital to the most promising private technology companies. With over $2.2
billion under management, Meritech seeks to lead investments in the portfolio
companies of leading early-stage venture capital firms and looks for
companies with proven and differentiated technology, rapidly-growing revenue
and seasoned management teams. As one of the most active late-stage
investors, Meritech provides guidance on a number of issues that rapidly
growing companies typically face, including management incentive plans, IPO
market timing and positioning, adviser selection, and post-IPO ownership
transition. Meritech is located in Palo Alto, CA and can be found at
http://www.meritechcapital.com.

Contacts:

    Abigail Marks
    UltraShape
    +972-4-909-9260
    abigail@ultrashape.com

    Paula Moggio
    FischerHealth
    +1-310-577-7870 x151
    pmoggio@fischerhealth.com

    Jessica Fishman
    Gitam Porter Novelli
    +972-3-576-5798
    jessica@gitam.co.il